Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma.

about

Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma.

Item

http://www.wikidata.org/entity/Q55396331

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Analyzing EGFR mutations and t ...... ents with lung adenocarcinoma.

@en

Analyzing EGFR mutations and t ...... ents with lung adenocarcinoma.

@nl

type

Item

label

Analyzing EGFR mutations and t ...... ents with lung adenocarcinoma.

@en

Analyzing EGFR mutations and t ...... ents with lung adenocarcinoma.

@nl

prefLabel

Analyzing EGFR mutations and t ...... ents with lung adenocarcinoma.

@en

Analyzing EGFR mutations and t ...... ents with lung adenocarcinoma.

@nl

P1476

Analyzing EGFR mutations and t ...... ents with lung adenocarcinoma.

@en

P2093

Bin Wang

http://www.w3.org/2001/XMLSchema#string

Boqing Li

http://www.w3.org/2001/XMLSchema#string

Huilin Zhao

http://www.w3.org/2001/XMLSchema#string

Junjie Liu

http://www.w3.org/2001/XMLSchema#string

Li Cai

http://www.w3.org/2001/XMLSchema#string

Pengzhou Gai

http://www.w3.org/2001/XMLSchema#string

Xiaomin Hua

http://www.w3.org/2001/XMLSchema#string

Xiuzhi Zhou

http://www.w3.org/2001/XMLSchema#string

Ying Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Inhibition of EGFR signaling: all mutations are not created equal.

Clinical characteristics and outcomes of patients with primary lung adenocarcinoma harboring ALK rearrangements detected by FISH, IHC, and RT-PCR.

Effectiveness of gefitinib against non-small-cell lung cancer with the uncommon EGFR mutations G719X and L861Q.

A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)

Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer.

A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry

EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer.

Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions.

P304

362-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8681

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29928422

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

6006462

http://www.w3.org/2001/XMLSchema#string